Methamphetamine causes coordinate regulation of Src, Cas, Crk, and the Jun N-terminal kinase-Jun pathway

Molecular Pharmacology

Volumn 61, Issue 5, 2002, Pages 1124-1131

  Jayanthi, Subramaniam ^a   McCoy, Michael T ^a   Ladenheim, Bruce ^a   Cadet, Jean Lud ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; CYTOKINE; GENE PRODUCT; METHAMPHETAMINE; PROTEIN CRK; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; MALE; MOUSE; NERVE DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRAL CORTEX; CORPUS STRIATUM; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENES, SRC; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; METHAMPHETAMINE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 10; MITOGEN-ACTIVATED PROTEIN KINASES; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 0036239242     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.61.5.1124     Document Type: Article

References (55)

1. Methamphetamine-induced increase in striatal NF-kappaB DNA-binding activity is attenuated in superoxide dismutase transgenic mice
2. A murine dopamine neuron-specific cDNA library and microarray increased COXI expression during methamphetamine neurotoxicity
3. The identification of p130cas-binding proteins and their role in cellular transformation
4. Free radicals and the pathobiology of brain dopamine systems
5. Temporal profiling of methamphetamine-induced changes in gene expression in the mouse brain: Evidence from cDNA array
6. c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves src-dependent epidermal growth factor receptor transactivation
7. Methamphetamine neurotoxicity: Necrotic and apoptotic mechanisms and relevance to human abuse and treatment
8. Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity
9. Methamphetamine causes widespread apoptosis in the mouse brain: Evidence from using an improved TUNEL histochemical method
10. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain
11. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms
12. Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study
13. Endothelin-1 and smooth muscle cells: Induction of Jun amino-terminal kinase through an oxygen radical-sensitive mechanism
14. Potentiation of estrogen receptor activation function 1 (AF-1) by Src/JNK through a serine 118-independent pathway
15. Transient forebrain ischemia in the adult gerbil is associated with a complex c,Jun response
16. Strong c,Jun/AP-1 immunoreactivity is restricted to apoptotic cells following intracerebral ibotenic acid injection in developing rats
17. Morphine induces apoptosis in murine thymocytes in vivo but not in vitro: Involvement of both opiate and glucocorticoid receptors
18. A single dose model of methamphetamine-induced neurotoxicity in rats: Effects on neostriatal monoamines and glial fibrillary acidic protein
19. Role of MAP kinase in neurons
20. Selective interaction of JNK protein kinase isoforms with transcription factors
21. Protein phosphorylation cascades associated with methamphetamine-induced glial activation
22. Lasting N-terminal phosphorylation of c,Jun and activation of c-Jun N-terminal kinases after neuronal injury
23. AP-1 proteins in the adult brain: Facts and fiction about effectors of neuroprotection and neurodegeneration
24. Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex
25. Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice
26. Amphetamine abuse. Pattern and effects of high doses taken intravenously
27. Clinical manifestations and prognostic features of acute methamphetamine intoxication
28. Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-kappaB in rats
29. Dopamine stimulates redox-tyrosine kinase signaling and p38 MAPK in activation of astrocytic C6-D2L cells
30. Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway
31. Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: An in vitro and in vivo study
32. Selective expression of JNK isoforms and stress-specific JNK activity in different neural cell lines
33. A novel SAPK/JNK kinase. MKK7, stimulated by TNFalpha and cellular stresses
34. Haloperidol-induced neuronal apoptosis: Role of p38 and c-Jun-NH(2)-terminal protein kinase
35. Methamphetamine-related stroke: Four cases
36. Brain transcription factor gene expression, neurotransmitter levels, and novelty response behaviors: Alterations during rat amphetamine withdrawal and following chronic injection stress
37. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide
38. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner
39. Glutamate, but not dopamine, stimulates stress-activated protein kinase and AP-1-mediated transcription in striatal neurons
40. Nitric oxide is a mediator of methamphetamine (METH)-induced neurotoxicity. In vitro evidence from primary cultures of mesencephalic cells
41. AP-1 DNA-binding activation by methamphetamine involves oxidative stress
42. Cognitive impairment in individuals currently using methamphetamine
43. Methamphetamine-induced neurotoxicity: Roles for glutamate and dopamine efflux
44. Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase
45. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
46. Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers
47. SEK1/MKK4, c-Jun and NFKappaB are differentially activated in forebrain neurons during postnatal development and injury in both control and p75NGFR-deficient mice
48. Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons
49. The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents
50. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users
51. Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene
52. Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species
53. Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia: The role of sensitization
54. Activation of JNK/SAPK in primary glial cultures: II. Differential activation of kinase isoforms corresponds to their differential expression